158 related articles for article (PubMed ID: 8243561)
1. Inhibitory effects of ibogaine on cocaine self-administration in rats.
Cappendijk SL; Dzoljic MR
Eur J Pharmacol; 1993 Sep; 241(2-3):261-5. PubMed ID: 8243561
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of antiaddictive actions of ibogaine.
Glick SD; Maisonneuve IS
Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
[TBL] [Abstract][Full Text] [Related]
3. Development of novel medications for drug addiction. The legacy of an African shrub.
Glick SD; Maisonneuve IM
Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
[TBL] [Abstract][Full Text] [Related]
4. Ibogaine reduces preference for cocaine consumption in C57BL/6By mice.
Sershen H; Hashim A; Lajtha A
Pharmacol Biochem Behav; 1994 Jan; 47(1):13-9. PubMed ID: 8115413
[TBL] [Abstract][Full Text] [Related]
5. Ibogaine antagonizes cocaine-induced locomotor stimulation in mice.
Sershen H; Hashim A; Harsing L; Lajtha A
Life Sci; 1992; 50(15):1079-86. PubMed ID: 1556903
[TBL] [Abstract][Full Text] [Related]
6. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum.
Glick SD; Kuehne ME; Raucci J; Wilson TE; Larson D; Keller RW; Carlson JN
Brain Res; 1994 Sep; 657(1-2):14-22. PubMed ID: 7820611
[TBL] [Abstract][Full Text] [Related]
7. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats.
Szumlinski KK; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 1999 Jul; 145(2):227-33. PubMed ID: 10463325
[TBL] [Abstract][Full Text] [Related]
9. Medication development of ibogaine as a pharmacotherapy for drug dependence.
Mash DC; Kovera CA; Buck BE; Norenberg MD; Shapshak P; Hearn WL; Sanchez-Ramos J
Ann N Y Acad Sci; 1998 May; 844():274-92. PubMed ID: 9668685
[TBL] [Abstract][Full Text] [Related]
10. Ibogaine-like effects of noribogaine in rats.
Glick SD; Pearl SM; Cai J; Maisonneuve IM
Brain Res; 1996 Mar; 713(1-2):294-7. PubMed ID: 8725004
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of memory retrieval by the "anti-addictive" alkaloid, ibogaine.
Popik P
Life Sci; 1996; 59(24):PL379-85. PubMed ID: 8950313
[TBL] [Abstract][Full Text] [Related]
12. Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.
Maisonneuve IM; Glick SD
Eur J Pharmacol; 1992 Mar; 212(2-3):263-6. PubMed ID: 1601069
[TBL] [Abstract][Full Text] [Related]
13. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.
Mash DC; Kovera CA; Pablo J; Tyndale RF; Ervin FD; Williams IC; Singleton EG; Mayor M
Ann N Y Acad Sci; 2000 Sep; 914():394-401. PubMed ID: 11085338
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener.
Glick SD; Maisonneuve IM; Szumlinski KK
Alkaloids Chem Biol; 2001; 56():39-53. PubMed ID: 11705115
[No Abstract] [Full Text] [Related]
15. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
Glick SD; Maisonneuve IM; Szumlinski KK
Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
[TBL] [Abstract][Full Text] [Related]
16. Iboga interactions with psychomotor stimulants: panacea in the paradox?
Szumlinski KK; Maisonneuve IM; Glick SD
Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
[TBL] [Abstract][Full Text] [Related]
17. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.
Maisonneuve IM; Keller RW; Glick SD
Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925
[TBL] [Abstract][Full Text] [Related]
18. Application of electrophysiological method to study interactions between ibogaine and cocaine.
Binienda Z; Beaudoin MA; Thorn BT; Sadovova N; Skinner RD; Slikker W; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():387-93. PubMed ID: 11085337
[TBL] [Abstract][Full Text] [Related]
19. Ibogaine and addiction in the animal model, a systematic review and meta-analysis.
Belgers M; Leenaars M; Homberg JR; Ritskes-Hoitinga M; Schellekens AF; Hooijmans CR
Transl Psychiatry; 2016 May; 6(5):e826. PubMed ID: 27244235
[TBL] [Abstract][Full Text] [Related]
20. Treating drug dependence with the aid of ibogaine: a retrospective study.
Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX
J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
